Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011881 (
diabetic nephropathy
)
10,836
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Previously we reported that the phosphorylation of
Synip
on serine 99 is required for
Synip
dissociation from Syntaxin4 and insulin-stimulated Glut4 translocation in cultured 3T3-L1 adipocytes. We also reported that the dissociated
Synip
remains anchored to the plasma membrane by binding to Phosphatidylinositol (3,4,5)-triphosphate. Recently
Synip
was reported to arrest SNARE-dependent membrane fusion as a selective t-SNARE binding inhibitor. In this study, we have found that
Synip
is expressed in podocytes although at a somewhat lower level than in adipocytes. To determine whether phosphorylation of
Synip
on serine 99 is required for insulin-stimulated Glut4 translocation and glucose uptake in podocytes we expressed a phosphorylation deficient
Synip
mutant (S99A-
Synip
) that inhibited insulin-stimulated Glut4 translocation and 2-deoxyglucose uptake in adipocytes. We conclude that serine 99 phosphorylation of
Synip
is required for Glut4 translocation and glucose uptake in both adipocytes and podocytes, suggesting that defects in
Synip
phosphorylation may underlie insulin resistance and associated
diabetic nephropathy
.
...
PMID:Synip phosphorylation is required for insulin-stimulated Glut4 translocation and glucose uptake in podocyte. 2470 89